You just read:

Actinium Pharmaceuticals Appoints Qing Liang, PhD, DABR as Vice President, Head of Radiation Sciences to Further Innovation for its AWE Technology Platform and Growing Pipeline of Antibody Radiation Conjugate Therapies

News provided by

Actinium Pharmaceuticals, Inc.

Jan 16, 2019, 08:00 ET